Ocugen, Inc. Common Stock
Here’s whether Ocugen, Inc. Common Stock (OCGN) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bullish.
Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+3.53% over 10 days); RSI 58 — healthy momentum range; strong 1-year return of +204.7%; 3-month momentum positive (+17.8%). Concerns: declining volume on rally — weak conviction (0.52x 30d avg). Currently 27.0% off its 52-week high. Score: +6/7.
OCGN is in a confirmed uptrend, trading above both its 50-day ($1.82) and 200-day ($1.44) moving averages. An RSI of 57.9 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of +204.7% compares to +35.1% for SPY (beat the market by 169.6%). The current 27.0% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.